Artificial respiration is means of assisting or stimulating respiration, a metabolic process referring to the overall exchange of gases in the body by pulmonary ventilation, external respiration, and internal respiration. It may take the form of manually providing air for a person who is not breathing or is not making sufficient respiratory effort, or it may be mechanical ventilation involving the use of a mechanical ventilator to move air in and out of the lungs when an individual is unable to breathe on their own, this machine is called ventilator; for example, during surgery with general anesthesia or when an individual is in a coma or trauma. Such methods, whenever connected rapidly and appropriately, can avert a few deaths from strangulation, drowning, choking, carbon monoxide poisoning, suffocation, and electric shock. Revival by prompting fake breath comprises primarily of two activities: setting up and keeping up an outside entry from the upper respiratory tract (throat, pharynx, and mouth) to the lungs and other is trading air and carbon dioxide in terminal air sacs of the lungs while heart is as yet working.
Covid-19 Scenario analysis:
Out of 20% of those infected in the current pandemic, the SARS CoV-2 viruses are lodged deep in the lungs, since COVID-19 mainly affects the lower respiratory tract. Then the illness quickly becomes critical, and the most severe cases must be immediately connected to a ventilator in the intensive care unit. Because there are too few intensive care beds with ventilators even in high-technology countries such as Italy and Spain, doctors are increasingly having to decide who gets the lifesaving treatment and who doesn't. Artificial respiration can save lives because if breathing stops, the organs are no longer supplied with oxygen. At the same time, the carbon dioxide produced during breathing is no longer exhaled via the lungs. A short time after a respiratory arrest, the heart also stops beating and the circulation ceases, so that the patient dies within minutes. During the coronavirus crisis, the demand for ventilators has increased dramatically because the health care systems in many countries are not geared to the need for so many respirators simultaneously. However, such high-performance ventilators for intensive care use, which cost up to €50,000 ($55,842) apiece, cannot be purchased at short notice. There are only a few manufacturers of ventilators and so-called ECMO devices, which can enrich the blood with oxygen, i.e. work as an artificial lung. Although these companies have increased their production capacities to the maximum, there are still supply bottlenecks, including for consumables such as breathing tubes and cannulas. Dramatic shortfalls in the care of seriously ill COVID-19 patients can also occur if, for example, illness or quarantine leads to a lack of highly qualified personnel who can reliably operate these sometimes highly complex devices in intensive care. Critically ill COVID-19 patients need artificial respiration. But there is a worldwide lack of equipment.
Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact analysis:
Drivers:
Climate change and pollution increasing Respiratory disorders:
Changes in climate constitute a reality that, according to recent projections, is going to worsen in the coming years. Climate change represents a massive threat to respiratory health: 1) by directly promoting or aggravating respiratory diseases; or 2) by increasing exposure to risk factors for respiratory diseases. Climate change increases the amount of pollen and allergen produced by each plant, mold proliferation and the concentrations of outdoor ozone and particulate matter at ground level. The main diseases of concerns are asthma, rhino sinusitis, chronic obstructive pulmonary disease (COPD) and respiratory tract infections. Groups at higher risk of climate change effects include individuals with pre-existing cardiopulmonary diseases or disadvantaged individuals. Adaptation and mitigation measures are strongly needed but also the need for artificial
Technological advancement:
A new technology that re-creates important characteristics of structures in the lung could eventually be a safer alternative to certain types of respiratory and cardiac machines used to treat people whose lungs have failed due to disease or injury. An alternative to mechanical ventilation is extracorporeal membrane oxygenation (ECMO), which entails drawing a patient’s blood and running it through a device that removes carbon dioxide and adds oxygen to it before returning the blood to the patient’s body. Traditionally, ECMO has been used mainly as a life-saving measure if mechanical ventilation doesn’t work or is impossible, and is more commonly used in children. Today’s ECMO machines, in which blood flows over a bundle of porous fibers through which oxygen is pumped, are complicated and require specialized expertise to operate. Blood tends to clot in the device, which is very unlike the environment in the lung, so patients must take large doses of anti-clotting medication. This can lead to other dangerous complications such as bleeding in the brain or gastrointestinal system. The technological advancements in respiratory devices globally will drive the market growth. The combination of healthcare and technology has resulted into software applications that collects the data from the respirator attached to ventilators. The data is used to provide appropriate treatment to the patient. Other advances include nasal cannula, oxygen regulator, trans-tracheal catheter that prove beneficial for artificial delivery of oxygen. Such developments will prove beneficial for artificial respirator industry.
Restrains:
However, stringent government regulations related to product approvals may hamper the growth of artificial respirator market over the analysis timeframe.
Key benefits of the report:
- This study presents the analytical depiction of the global artificial respirator industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global artificial respirator market share.
- The current market is quantitatively analyzed to highlight the global artificial respirator market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the artificial respirator market.
- The report provides a detailed global artificial respirator market analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in the artificial respirator market research report:
- Which are the leading market players active in the artificial respirator market?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities in the market?
- What are the projections for the future that would help in taking further strategic steps?
Artificial Respirator Market Report Highlights
| Aspects | Details |
 By Type |
|
 By Material |
|
 By End User |
|
 By Region |
|
 Key Market Players | Ambu,, Acutronic Medical Systems,, HOFFRICHTER GmbH,, CareFusion,, Drager,, Fisher & Paykel Healthcare,, GaleMed., ResMed,, Air Liquide Healthcare,, Phillips, |
Loading Table Of Content...
